Budget 2021-2022 minimizes regulatory compliance burden to improve ‘Ease of Doing Business’ for industry: DPIIT Secretary
A Regulatory Compliance Portal has been launched by the DPIIT on 1st January 2021.
A Regulatory Compliance Portal has been launched by the DPIIT on 1st January 2021.
The Budget launched PLI schemes for 13 sectors, with an outlay of Rs 1.97 lakh crore, for a period of 5 years starting from FY 2021- 22.
The company posted net profit of Rs.0.90 crores for the period ended December 31, 2019.
The company has posted net profit of Rs.72.11 crores for the 9 months period ended December 31, 2020.
The company posted net profit of Rs.31.47 crores for the quarter ended December 31, 2019.
The company posted net profit of Rs.6.63 crores for the period ended December 31, 2019.
The company posted net profit of Rs.2.28 crores for the period ended December 31, 2019.
The company posted net profit of Rs.78.42 crores for the period ended December 31, 2019.
The company posted net profit of Rs.2.16 crores for the period ended December 31, 2019.
Gujarat Gas has posted net profit of Rs.197.30 crores for the period ended December 31, 2019.
Gulf Oil Lubricants India has posted net profit of Rs.140.30 crores for the 9 months period ended December 31, 2020.
Gulf India will become a shareholder with CGF and GOI in Indra, alongside OVO Group.
The company's business in India geography posted strong growth during the quarter as it grew by 20% on a y-o-y basis and registered revenues of Rs. 1,643 crore.
The company has posted net profit of Rs.397.06 crores for the 9 months period ended December 31, 2020.
The company posted net loss of Rs. 661.16 crores for the period ended December 31, 2019.
The plants are due to be completed in 2024
Gangl shall assume the charge from 1 April 2021
The facilities are expected to begin operations in 2021
Building on its leadership in sustainability, Firmenich has committed to ground-breaking goals across three key areas: acting on climate change, embracing nature, and caring for people
WACKER and Helixmith plan to strategically collaborate on the production of a pDNA gene therapy developed by Helixmith for the treatment of diabetic peripheral neuropathy (DPN).
Subscribe to our newsletter & stay updated.